Thierry Lioux

811 total citations
16 papers, 681 citations indexed

About

Thierry Lioux is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Thierry Lioux has authored 16 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Thierry Lioux's work include Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Thierry Lioux is often cited by papers focused on Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Thierry Lioux collaborates with scholars based in France, Japan and Spain. Thierry Lioux's co-authors include Éric Pérouzel, Fabienne Vernejoul, Stéphane Paul, Bernard Verrier, Gérard Tiraby, Nicolas Rochereau, Cédric Boularan, Vincent Pavot, Christian Genin and Christophe Mathé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Thierry Lioux

16 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Lioux France 12 516 278 204 112 68 16 681
Thomas Démoulins Switzerland 17 584 1.1× 530 1.9× 150 0.7× 78 0.7× 121 1.8× 31 948
Alex S. Powlesland United Kingdom 9 284 0.6× 267 1.0× 87 0.4× 59 0.5× 75 1.1× 12 507
Armando Stano Switzerland 12 474 0.9× 387 1.4× 151 0.7× 109 1.0× 83 1.2× 13 906
Paula Wolf Bryant United States 10 369 0.7× 231 0.8× 47 0.2× 104 0.9× 40 0.6× 11 593
Thomas Hagan United States 8 281 0.5× 246 0.9× 138 0.7× 140 1.3× 25 0.4× 12 581
Ryan J. Malonis United States 9 202 0.4× 442 1.6× 126 0.6× 84 0.8× 69 1.0× 12 657
Ans De Beuckelaer Belgium 13 369 0.7× 441 1.6× 106 0.5× 38 0.3× 86 1.3× 14 758
Cynthia M. Fehres Netherlands 13 556 1.1× 302 1.1× 40 0.2× 73 0.7× 106 1.6× 29 750
Shoukang Luo United States 4 161 0.3× 212 0.8× 178 0.9× 167 1.5× 101 1.5× 5 550
Kevin B. Gurney United States 11 460 0.9× 189 0.7× 138 0.7× 129 1.2× 42 0.6× 15 684

Countries citing papers authored by Thierry Lioux

Since Specialization
Citations

This map shows the geographic impact of Thierry Lioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lioux more than expected).

Fields of papers citing papers by Thierry Lioux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lioux. The network helps show where Thierry Lioux may publish in the future.

Co-authorship network of co-authors of Thierry Lioux

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lioux. A scholar is included among the top collaborators of Thierry Lioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lioux. Thierry Lioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vernejoul, Fabienne, et al.. (2023). 1161 Development of TLR7- and STING-conjugatable agonists for immunostimulatory ADC-based cancer therapies. SHILAP Revista de lepidopterología. A1280–A1280. 1 indexed citations
2.
Gutjahr, Alice, Laura Papagno, Fabienne Vernejoul, et al.. (2020). New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses. EBioMedicine. 58. 102922–102922. 24 indexed citations
3.
Gutjahr, Alice, Laura Papagno, Francesco Nicoli, et al.. (2019). The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells. JCI Insight. 4(7). 74 indexed citations
4.
Thomsen, Martin K., Morten Kelder Skouboe, Cédric Boularan, et al.. (2019). The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene. 39(8). 1652–1664. 84 indexed citations
5.
Skouboe, Morten Kelder, Alice Knudsen, Line S. Reinert, et al.. (2018). STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice. PLoS Pathogens. 14(4). e1006976–e1006976. 43 indexed citations
6.
Decout, Alexiane, Sandro Silva‐Gomes, Daniel Drocourt, et al.. (2017). Rational design of adjuvants targeting the C-type lectin Mincle. Proceedings of the National Academy of Sciences. 114(10). 2675–2680. 89 indexed citations
7.
Gutjahr, Alice, Laura Papagno, Francesco Nicoli, et al.. (2017). Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses. The Journal of Immunology. 198(11). 4205–4209. 32 indexed citations
8.
Lioux, Thierry, et al.. (2016). Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine–Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING). Journal of Medicinal Chemistry. 59(22). 10253–10267. 103 indexed citations
9.
Pavot, Vincent, Núria Climent, Nicolas Rochereau, et al.. (2015). Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands. Biomaterials. 75. 327–339. 46 indexed citations
10.
Climent, Núria, Vincent Pavot, Felipe García, et al.. (2014). Co-delivery of Antigen p24 and NOD-ligands by PLA Nanoparticles to Human Dendritic Cells Promote Highly Functional HIV-1-Specific T-cell Responses. AIDS Research and Human Retroviruses. 30(S1). A240–A241. 1 indexed citations
11.
Pavot, Vincent, Nicolas Rochereau, Julien Rességuier, et al.. (2014). Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity. The Journal of Immunology. 193(12). 5781–5785. 59 indexed citations
12.
Pavot, Vincent, Nicolas Rochereau, Charlotte Primard, et al.. (2013). Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties. Journal of Controlled Release. 167(1). 60–67. 74 indexed citations
13.
Mathé, Christophe, Thierry Lioux, & Gilles Gosselin. (2003). Synthesis and Biological Evaluation of β-D-Pentofuranonucleoside Derivatives of 2-Azidoadenine and 6-Azidopurines. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 605–609. 12 indexed citations
14.
Lioux, Thierry, Gilles Gosselin, & Christophe Mathé. (2003). Azido/Tetrazole Tautomerism in 2‐Azidoadenine β‐D‐Pentofuranonucleoside Derivatives. European Journal of Organic Chemistry. 2003(20). 3997–4002. 32 indexed citations
15.
IMBACH, J.‐L., et al.. (2000). 40 High cellular uptake of lipophilic oligonucleotide prodrugs. Antiviral Research. 46(1). A47–A47. 1 indexed citations
16.
Marchand, Arnaud, Thierry Lioux, Christophe Mathé, Jean‐Louis Imbach, & Gilles Gosselin. (1999). Stereospecific synthesis of unnatural β-L-enantiomers of 2-chloroadenine pentofuranonucleoside derivatives. Journal of the Chemical Society Perkin Transactions 1. 2249–2254. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026